ArticleHuman vaccines & immunotherapeutics2025

Immunogenicity and safety of HepE Hecolin® in chronic hepatitis B patients at clinically stable stage: An open-label study in China.

Li Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.